Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus

Journal of Pineal Research

Volumn 32, Issue 1, 2002, Pages 6-14

  Venero, José L ^a   Absi, El Hadi ^a   Cano, Josefina ^a   Machado, Alberto ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Arcuate nucleus; Dopamine transporter; Melatonin; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

DOPAMINE TRANSPORTER; GLUTAMATE DECARBOXYLASE; MELATONIN; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN SYNAPTOSOME; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; ENZYME INDUCTION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; SUPRAOPTIC NUCLEUS; TISSUE SPECIFICITY; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATE DECARBOXYLASE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MELATONIN; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; NERVE DEGENERATION; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 0036161567     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079x.2002.10813.x     Document Type: Article

References (60)

1. Melatonin is protective against MPTP-induced striatal and hippocampal lesions
2. Recombinant human erythropoietin: Possible role as an antioxidant in premature rabbits
3. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis
4. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
5. Regulation of endogenous dopamine release in amphibian retina by melatonin: The role of GABA
6. Resetting the circadian clock in cultured Xenopus eyecups: Regulation of retinal melatonin rhythms by light and D2 dopamine receptors
7. Effects of melatonin on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus
8. Age-related changes of neuronal responsiveness to melatonin in the striatum of sham-operated and pine-alectomized rats
9. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs
10. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs
11. Protection from oxidation enhances the survival of cultured mesencephalic neurons
12. Melatonin and abnormal movements induced by L-dopa in mice
13. Oxidative stress, glutamate, and neurodegenerative disorders
14. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells
15. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
16. Chrono-neuroendocrinological aspects of physiological ageing and senile dementia
17. Melatonin is a potent modulator of dopamine release in the retina
18. Pharmacology and function of melatonin receptors
19. Two genes encode distinct glutamate decarboxylase
20. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
21. On the origin and significance of neuromelanin
22. Hypoxia during early developmental period induces long-term changes in the dopamine content and release in a mesencephalic cell culture
23. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
24. Does oxidative stress participate in nerve cell death in Parkinson's disease?
25. Functional interaction of melatonin receptors and D1 dopamine receptors in cultured chick retinal neurons
26. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats
27. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats
28. Intricate regulation of tyrosine hydroxylase activity and gene expression
29. BDNF and NGF in lesioned rats: Effects on cholinergic function and weight gain
30. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
31. Melatonin suppresses iron-induced neurodegeneration in rat brain
32. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion
33. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: Implications for Parkinson's disease
34. Dopamine transporter mRNA neurons of the rat hypothalamus
35. Effects of pinealectomy and melatonin treatments on serotonin uptake and release from synaptosomes of rat hypothalamic regions
36. Pathophysiology of the basal ganglia in Parkinson's disease
37. A radical hypothesis for neurodegeneration
38. Etiology and pathogenesis of Parkinson's disease
39. Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3′-untranslated region
40. The pineal control of ageing. The effects of melatonin and pineal grafting on the survival of older mice
41. The involvement of pineal gland and melatonin in immunity and ageing. I. Thymus-mediated, immunoreconstituting and antiviral activity of thyrotropin-releasing hormone
42. Oxidative damage in the central nervous system: Protection by melatonin
43. Prophylactic actions of melatonin in oxidative neurotoxicity
44. A review of the evidence supporting melatonin's role as an antioxidant
45. Pineal melatonin rhythm: Reduction in ageing Syrian hamsters
46. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA
47. Melatonin free radicals and cancer initiation
48. Melatonin as a free radical scavenger: Implications for ageing and age-related diseases
49. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine
50. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
51. Quantitative pharmacological analysis of 2-125-I-iodomelatonin binding sites in discrete areas of the chicken brain
52. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen
53. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments
54. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
55. Characterization of the short day-induced decrease in median eminence tyrosine hydroxylase activity in the ewe: Temporal relationship to the changes in lutenizing hormone and prolactin secretion and short day-like effect of melatonin
56. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels
57. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons
58. Catecholamine receptors regulating serotonin N-acetyltransferase activity and melatonin content of chicken retina and pineal gland: D2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland
59. Inhibition of dopamine release by melatonin: Regional distribution in the rat brain